Javara has announced a strategic partnership with Nevada Health Centers (NVHC). Javara will employ and embed clinical research professionals within NVHC clinics to work alongside physicians and medical staff, providing aspects of operational collaboration to deliver clinical trials as a care option to their patients. The immediate focus of this new partnership is the NVHC Reno and Carson City locations. Javara and NVHC anticipate activation of the first clinical trials in internal medicine in the fall of 2023.
“As an FQHC (Federally Qualified Health Center), many patients served by Nevada Health Centers are from regions and demographic groups that have traditionally been sorely underrepresented in clinical trials,” said Jennifer Byrne, Javara founder and CEO. “Javara is grateful for the trust of Nevada Health Centers to bring access to novel treatments and innovative health care options to these communities for the first time. With a special focus on those patients with unmet medical needs in geographically isolated and otherwise marginalized regions, we are fully committed to the community benefit this partnership brings.”
“When seeking a partner to guide Nevada Health Centers’ efforts to develop a clinical trials program for our patients, Javara most closely aligned with our organizational mission and vision,” said Walter Davis, Nevada Health Centers' CEO. “We are a safety net provider for the community, and many of our patients live with chronic conditions. This partnership enables us to offer both access to innovative treatments and advanced education to our patients and establish a greater sense of trust in research. We are excited to be positioned as a contributor to the scientific knowledge base that helps improve the delivery and understanding of medicine.”
Javara, Nevada Health Centers Announce Partnership to Bring Clinical Research to the Geographically Isolated, Medically Underserved. (2023, August 7). Business Wire.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.